A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade⢠Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation
Titel:
A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade⢠Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation
Auteur:
Seiwert, T.Y. Darga, T. Haraf, D. Blair, E.A. Stenson, K. Cohen, E.E.W. Salama, J.K. Villaflor, V. Witt, M.E. Lingen, M.W. Weichselbaum, R.R. Vokes, E.E.